Viewing Study NCT06668493


Ignite Creation Date: 2025-12-25 @ 1:17 AM
Ignite Modification Date: 2025-12-25 @ 11:26 PM
Study NCT ID: NCT06668493
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2024-10-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Sponsor: Ferring Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module